Surgery Partners (SGRY)
(Real Time Quote from BATS)
$32.62 USD
-0.51 (-1.54%)
Updated Sep 20, 2024 10:16 AM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Balance Sheet
Fiscal Year End for Surgery Partners, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 196 | 283 | 390 | 318 | 93 |
Receivables | 496 | 456 | 430 | 382 | 327 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 75 | 71 | 61 | 56 | 46 |
Other Current Assets | 128 | 110 | 65 | 45 | 60 |
Total Current Assets | 895 | 921 | 946 | 802 | 526 |
Net Property & Equipment | 969 | 877 | 630 | 545 | 523 |
Investments & Advances | 184 | 190 | 89 | 90 | 93 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 90 | 92 | 114 | 125 | 99 |
Intangibles | 4,381 | 4,179 | 3,956 | 3,515 | 3,450 |
Deposits & Other Assets | 103 | 144 | 59 | 27 | 329 |
Total Assets | 6,877 | 6,682 | 6,118 | 5,413 | 5,019 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 172 | 152 | 125 | 100 | 97 |
Current Portion Long-Term Debt | 73 | 63 | 60 | 64 | 56 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 74 | 72 | 142 | 175 | 54 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 204 | 207 | 210 | 217 | 191 |
Total Current Liabilities | 523 | 493 | 537 | 557 | 398 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,702 | 2,559 | 2,878 | 2,792 | 2,525 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 41 | 75 | 87 | 140 | 397 |
Minority Interest (Liabilities) | 327 | 342 | 330 | 307 | 321 |
Total Liabilities | 3,842 | 3,741 | 4,148 | 4,097 | 3,641 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 435 | 395 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 2,498 | 2,478 | 1,622 | 608 | 663 |
Retained Earnings | -569 | -557 | -503 | -432 | -316 |
Other Equity | 1,105 | 1,019 | 849 | 706 | 636 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 3,035 | 2,941 | 1,970 | 1,317 | 1,378 |
Total Liabilities & Shareholder's Equity | 6,877 | 6,682 | 6,118 | 5,413 | 5,019 |
Total Common Equity | 3,035 | 2,941 | 1,970 | 882 | 983 |
Shares Outstanding | 126.40 | 125.90 | 89.30 | 50.40 | 50.00 |
Book Value Per Share | 24.01 | 23.36 | 22.06 | 17.50 | 19.67 |
Fiscal Year End for Surgery Partners, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 214 | 185 | 196 | 236 | 177 |
Receivables | 523 | 494 | 496 | 463 | 450 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 81 | 77 | 75 | 69 | 70 |
Other Current Assets | 195 | 139 | 128 | 108 | 113 |
Total Current Assets | 1,013 | 896 | 895 | 876 | 810 |
Net Property & Equipment | 1,006 | 983 | 969 | 940 | 826 |
Investments & Advances | 227 | 189 | 184 | 196 | 192 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 82 | 87 | 90 | 105 | 106 |
Intangibles | 4,859 | 4,451 | 4,381 | 4,301 | 4,291 |
Deposits & Other Assets | 36 | 112 | 103 | 117 | 128 |
Total Assets | 7,489 | 6,976 | 6,877 | 6,780 | 6,621 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 174 | 174 | 172 | 149 | 132 |
Current Portion Long-Term Debt | 92 | 77 | 73 | 62 | 65 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 63 | 69 | 74 | 82 | 64 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 222 | 204 | 204 | 208 | 198 |
Total Current Liabilities | 552 | 523 | 523 | 501 | 459 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 3,040 | 2,794 | 2,702 | 2,640 | 2,505 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 21 | 41 | 79 | 82 | |
Minority Interest (Liabilities) | 442 | 324 | 327 | 332 | 328 |
Total Liabilities | 4,312 | 3,938 | 3,842 | 3,794 | 3,638 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 2,511 | 2,496 | 2,498 | 2,495 | 2,501 |
Retained Earnings | -597 | -582 | -569 | -568 | -563 |
Other Equity | 1,261 | 1,123 | 1,105 | 1,059 | 1,043 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 3,176 | 3,038 | 3,035 | 2,987 | 2,983 |
Total Liabilities & Shareholder's Equity | 7,489 | 6,976 | 6,877 | 6,780 | 6,621 |
Total Common Equity | 3,176 | 3,038 | 3,035 | 2,987 | 2,983 |
Shares Outstanding | 127.10 | 127.10 | 126.40 | 126.50 | 126.50 |
Book Value Per Share | 24.99 | 23.90 | 24.01 | 23.61 | 23.58 |